Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene

Journal of Comparative Neurology

Volumn 394, Issue 4, 1998, Pages 506-519

  Anderson, T J ^a   Schneider, A ^b   Barrie, J A ^a   Klugmann, M ^b   Mcculloch, M C ^a   Kirkham, D ^a   Kyriakides, E ^a   Nave, K A ^b   Griffiths, I R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Axonal degeneration; Demyelination; Pelizaeus Merzbacher disease

Indexed keywords

PROTEOLIPID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DEMYELINATION; GENE MUTATION; MOUSE; NERVE DEGENERATION; NONHUMAN; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; TREMOR;

EID: 0032543261     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19980518)394:4<506::AID-CNE8>3.0.CO;2-5     Document Type: Article

References (62)

1. Balmain, A., R. Krumlauf, J.K. Vass, and G.D. Birnie (1982) Cloning and characterisation of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res. 10:4259-4277.
2. Bonneau, D., J.-M. Rozet, C. Bulteau, M. Berthier, R. Mettey, R. Gil, A. Munnich, and M. Le Merrer (1993) X-linked spastic paraplegia (SPG2): Clinical heterogeneity at a single locus. J. Med. Genet. 30:381-384.
3. Bruyn, G.W., H.R. Weenink, G.T.A.M. Bots, J.L.J.M. Teepen, and W.J.A. van Wolferen (1985) Pelizaeus-Merzbacher disease (the Lowenberg-Hill type). Acta Neuropathol. (Berlin) 67:177-189.
4. Butt, A.M. and H.G. Jenkins (1994) Morphological changes in oligodendrocytes in the intact mouse optic nerve following intravitreal injection of tumour necrosis factor. J. Neuroimmunol. 51:27-33.
5. Chiang, C.S., H.C. Powell, L.H. Gold, A. Samimi, and I.L. Campbell (1996) Macrophage microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J. Clin. Invest. 97:1512-1524.
6. Coetzee, T., N. Fujita, J. Dupree, R. Shi, A. Blight, K. Suzuki, and B. Popko (1996) Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability. Cell 86:209-213.
7. Cremers, F.P.M., R.A. Pfeiffer, T.J.R. van de Pol, M.H. Hofker, T.A. Kruse, B. Wieringa, and H.H. Ropers (1987) An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum. Genet. 77:23-27.
8. De Waegh, S.M. and S.T. Brady (1991) Local control of axonal properties by Schwann cells: Neurofilaments and axonal transport in homologous and heterologous nerve grafts. J. Neurosci. Res. 30:201-212.
9. De Waegh, S.M., V.M.Y. Lee, and S.T. Brady (1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68:451-463.
10. Dentinger, M.P., K.D. Barron, and C.K. Csiza (1982) Ultrastructure of the central nervous system in a myelin deficient rat. J. Neurocytol. 11:671-691.
11. Duncan, I.D., J.P. Hammang, and B.D. Trapp (1987) Abnormal compact myelin in the myelin-deficient rat: Absence of proteolipid protein correlates with a defect in the intraperiod line. Proc. Natl. Acad. Sci. USA 84:6287-6291.
12. Ellis, D. and S. Malcolm (1994) Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nature Genet. 6:333-334.
13. Fanarraga, M.L., I.R. Griffiths, M.C. McCulloch, J.A. Barrie, P.G.E. Kennedy, and P.J. Brophy (1992) Rumpshaker: An X-linked mutation causing hypomyelination. Developmental differences in myelination and glial cells between the optic nerve and spinal cord. Glia 5:161-170.
14. Gehrmann, J., Y. Matsumoto, and G.W. Kreutzberg (1995) Microglia: Intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:269-287.
15. 0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons. Cell 71:565-576.
16. Ginter, D.N., B.A. Konigsmark, and M.H. Abbott (1974) X-linked spinocerebellar degeneration. Birth Defects OAS X4:334-336.
17. Gravel, M., J. Peterson, V.W. Yong, V. Kottis, B. Trapp, and P.E. Braun (1996) Overexpression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase in transgenic mice alters oligodendrocyte development and produces aberrant myelination. Mol. Cell. Neurosci. 7:453-466.
18. Griffiths, I.R. (1996) Myelin mutants: Model systems to study normal and abnormal myelination. Bioessays 18:789-797.
19. Griffiths, I.R., L.S. Mitchell, K. McPhilemy, S. Morrison, E. Kyriakides, and J.A. Barrie (1989) Expression of myelin protein genes in Schwann cells. J. Neurocytol. 18:345-352.
20. Griffiths, I.R., I. Scott, M.C. McCulloch, J.A, Barrie, K. McPhilemy, and B.M. Cattanach (1990) Rumpshaker mouse: A new X-linked mutation affecting myelination: Evidence for a defect in PLP expression. J. Neurocytol. 19:273-283.
21. Griffiths, I.R., A. Schneider, J. Anderson, and K.-A. Nave (1995) Transgenic and natural mouse models of proteolipid protein (PLP) related dysmyelination and demyelination. Brain Pathol. 5:275-281.
22. Griffiths, I.R., M. Klugmann, T.J. Anderson, M.H. Schwab, M. Jung, F. Zimmermann, and K.-A. Nave (1997) Mouse models of dysmyelinating diseases: Axonal degeneration and glial cell death [abstract]. J. Neurochem. 69:S257.
23. Hartman, B.K., H.C. Agrawal, D. Agrawal, and S. Kalmbach (1982) Development and maturation of central nervous system myelin: Comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes. Proc. Natl. Acad. Sci. USA 79:4217-4220.
24. Hildebrand, C. (1971) Ultrastructural and light-microscopic studies of the developing feline spinal cord white matter. I. The nodes of Ranvier. Acta Physiol. Scand. 364(Suppl.):81-108.
25. Hildebrand, C., S. Remahl, H. Persson, and C. Bjartmar (1993) Myelinated nerve fibres in the CNS. Progr. Neurobiol. 40:319-384.
26. Hodes, M.E. and S.R. Dlouhy (1996) The proteolipid protein gene: Double, double, . . . and trouble. Am. J. Hum. Genet. 59:12-15.
27. Hodes, M.E., V.M. Pratt, and S.R. Dlouhy (1993) Genetics of Pelizaeus-Merzbacher disease. Dev. Neurosci. 15:383-394.
28. Huxley, C., E. Passage, A. Manson, G. Putzu, D. Figarella-Branger, J.F. Pellissier, and M. Fontés (1996) Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum. Mol. Genet. 5:563-569.
29. Inoue, K., H. Osaka, N. Sugiyama, C. Kawanishi, H. Onishi, A. Nezu, K. Kimura, S. Kimura, Y. Yamada, and K. Kosaka (1996) A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am. J. Hum. Genet. 59:32-39.
30. Inoue, Y., T. Kagawa, Y. Matsumura, K. Ikenaka, and K. Mikoshiba (1996) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci. Res. 25:161-172.
31. Johnson, R.S., J.C. Roder, and J.R. Riordan (1995) Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J. Neurochem. 64:967-976.
32. Johnston, A.W. and V.A. McKusick (1962) A sex-linked recessive form of spastic paraplegia. Am. J. Hum. Genet. 14:83-94.
33. Kagawa, T., K. Ikenaka, Y. Inoue, S. Kuriyama, T. Tsujii, J. Nakao, K. Nakajima, J. Aruga, H. Okano, and K. Mikoshiba (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427-442.
34. Keppen, L.D., M.F. Leppert, P. O'Connell, Y. Nakamura, D. Stauffer, M. Lathrop, J.-M. Laloeul, and R. White (1987) Etiological heterogeneity in X-linked spastic paraplegia. Am. J. Hum. Genet. 41:933-943.
35. Kirkpatrick, L.L. and S.T. Brady (1994) Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells. J. Neurosci. 14:7440-7450.
36. Klugmann, M., M.H. Schwab, A. Pühlhofer, A. Schneider, F. Zimmermann, I.R. Griffiths, and K.-A. Nave (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59-70.
37. Kobayashi, H., E.P. Hoffman, and H.G. Marks (1994) The rumpshaker mutation in spastic paraplegia. Nature Genet. 7:351-352.
38. Kobayashi, H., C.A. Garcia, G. Alfonso, H.G. Marks, and E.P. Hoffman (1996) Molecular genetics of familial spastic paraplegia: A multitude of responsible genes. J. Neurol. Sci. 137:131-138.
39. Koeppen, A.H., N.A. Ronca, E.A. Greenfield, and M.B. Hans (1987) Defective biosynthesis of proteolipid protein in Pelizaeus-Merzbacher disease. Ann. Neurol. 21:159-170.
40. Lassmann, H., U. Bartsch, D. Montag, and M. Schachner (1997) Dying-back oligodendrogliopathy: A late sequel of myelin-associated glycoprotein deficiency. Glia 19:104-110.
41. Lees, M.B. and S.W. Brostoff (1984) Proteins of myelin. In P. Morell (ed): Myelin. New York: Plenum Press, pp. 197-224.
42. Löwenberg, K. and T.S. Hill (1933) Diffuse sclerosis with preserved myelin islands. Arch. Neurol. Psychiatr. 29:1232-1245.
43. Ludwin, S.K. (1997) The pathobiology of the oligodendrocyte. J. Neuropathol. Exp. Neurol. 56:111-124.
44. Magyar, J.P, R. Martini, T. Ruelicke, A. Aguzzi, K. Adlkofer, Z. Dembic, J. Zielasek, K.V. Toyka, and U. Suter (1996) Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J. Neurosci. 16:5351-5360.
45. Mastronardi, F.G., C.A. Ackerley, L. Arsenault, B.I. Roots, and M.A. Moscarello (1993) Demyelination in a transgenic mouse: A model for multiple sclerosis. J. Neurosci. Res. 36:315-324.
46. McLean, I.W. and P.K. Nakane (1974) Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoeleetron microscopy. J. Histochem. Cytochem. 12:1077-1083.
47. Milner, R.J., C. Lai, K.-A. Nave, D. Lenoir, J. Ogata, and J.G. Sutcliffe (1985) Nucleotide sequence of two mRNAs for rat brain myelin proteolipid protein. Cell 42:931-939.
48. Mitchell, L.S., C.S. Gillespie, F. McAllister, M.L. Fanarraga, D. Kirkham, B. Kelly, P.J. Brophy, I.R. Griffiths, P. Montague, and P.G.E. Kennedy (1992) Developmental expression of the major myelin protein genes in the CNS of the X-linked hypomyelinating mutant rumpshaker. J. Neurosci. Res. 33:205-217.
49. Montague, P., P.J. Dickinson, A.S. McCallion, G.J. Stewart, A. Savioz, R.W. Davies. P.G.E. Kennedy, and I.R. Griffiths (1997) Developmental expression of the murine Mobp gene. J. Neurosci. Res. 49:133-143.
50. Nance, M.A., S. Boyadjiev, V.M. Pratt, S. Taylor, M.E. Hodes, and S.R. Dlouhy (1996) Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease. Neurology 47:1333-1335.
51. Nave, K.-A. (1996) Myelin-specific genes and their mutations in the mouse. In K.R. Jessen and W.D. Richardson (eds): Glial Cell Development. Basic Principles and Clinical Relevance. Oxford: Bios, pp. 141-164.
52. Nave, K.-A. and O. Boespflug-Tanguy (1996) X-linked developmental defects in myelination: From mouse mutants to human genetic diseases. Neuroscientist 2:33-43.
53. Probert, L., K. Akassoglou, M. Pasparakis, G. Kontogeorgos, and G. Kollias (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 92:11294-11298.
54. Raskind, W.H., C.A. Williams, L.D. Hudson, and T.D. Bird (1991) Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am. J. Hum. Genet. 49:1355-1360.
55. Readhead, C., A. Schneider, I.R. Griffiths, and K.-A. Nave (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583-595.
56. Saugier-Veber, P., A. Munnich, D. Bonneau, J.-M. Rozet, M. Le Merrer, R. Gil, and O. Boespflug-Tanguy (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nature Genet. 6:257-262.
57. Seitelberger, F. (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol. 5:267-273.
58. Seitelberger, F., S. Urbanits, and K.-A. Nave (1996) Pelizaeus-Merzbacher disease. In H.W. Moser (ed): Neurodystrophies and Neurolipidoses. Amsterdam: Elsevier Science, pp. 559-579.
59. Sereda, M., I.R. Griffiths, A. Pühlhofer, H. Stewart, M.J. Rossner, F. Zimmermann, J.P. Magyar, A. Schneider, E. Hund, H.M. Meinck, U. Suter, and K.-A. Nave (1996) A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 16:1049-1060.
60. Sistermans, E.A., I.J. De Wijs, I.F.M. De Coo, and B.A. Van Oost (1996) Duplication of the proteolipid protein gene (PLP) is a frequent cause of Pelizaeus Merzbacher disease [abstract]. Am. J. Hum. Genet. 10:A10.
61. Snipes, G.J. and U. Suter (1995) Molecular basis of common hereditary motor and sensory neuropathies in humans and in mouse models. Brain Pathol. 5:233-247.
62. Williams, M.A. (1977) Stereological techniques. In A.M. Glauert (ed): Practical Methods in Electron Microscopy, Vol. 6: Quantitative Methods in Biology. Amsterdam: North Holland, pp. 5-84.